AI
Monday, October 14, 2019 10:37:00 PM
SunGen’s three CNS stimulants
1.) SunGen#1 Generic Adderall approved - $400 M market
2.)SunGen#2 approval coming Dec 2019 $1.6 Billion market only 3 *authorized * generic competitors PDUFA date Dec 2019
3.)SunGen#5 to be filed at any time $1.5 Billion market ER combination CNS stimulant
- $3.5 Billion plus + combined market
Everyone you meet is fighting a battle you know nothing about BE KIND
Recent ELTP News
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
